• We are sorry, but NCBI web applications do not support your browser and may not function properly. More information
Figure F-31 is titled “PTSD symptom reduction for exposure therapy compared with stress inoculation therapy, by instrument: Sensitivity analysis studies with high risk of bias.” This figure displays a forest plot reporting the standardized mean difference in PTSD symptom scores, as measured by the PSS-I and other instruments, for exposure therapy compared to stress inoculation therapy. The plot depicts greater PTSD symptom reduction for patients treated with exposure therapy compared to stress inoculation therapy, as measured by the PSS-I (1 trial, standardized mean difference −0.14, 95% CI −0.69 to 0.41). Conversely, the plot depicts a greater reduction in PTSD symptoms for patients treated with stress inoculation therapy than exposure therapy, as measured by other instruments (1 trial, standardized mean difference 0.40, 95% CI −0.42 to 1.22). The overall analysis favors stress inoculation therapy (standardized mean difference 0.04, 95% CI −0.46 to 0.54, I2 = 13.1%).

Figure F-31PTSD symptom reduction for exposure therapy compared with stress inoculation therapy, by instrument: sensitivity analysis including studies with high risk of bias

Note: Foa et al., 1991 was rated as having a high risk of bias.

Timing of outcome assessment: 9 weeks for both studies

From: Appendix F, Meta-Analysis

Cover of Psychological and Pharmacological Treatments for Adults With Posttraumatic Stress Disorder (PTSD)
Psychological and Pharmacological Treatments for Adults With Posttraumatic Stress Disorder (PTSD) [Internet].
Comparative Effectiveness Reviews, No. 92.
Jonas DE, Cusack K, Forneris CA, et al.

NCBI Bookshelf. A service of the National Library of Medicine, National Institutes of Health.